Loading
CA
Carasent ASA Stock: price and insider trades · Norway
No insider purchase over the last 90 days. The latest was filed 22 Nov 2024.
Carasent ASA: what insiders have been doing
Carasent ASA, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to Oslo Børs. Nothing new has been filed by managers of Carasent ASA in twelve months, the latest record being from 5 December 2024.
In the same sector, recent insider purchases at Relmada Therapeutics, Inc. and MAIA Biotechnology, Inc. also feature in our signals. These figures are compiled from regulatory filings published by Oslo Børs. They describe what insiders did and are not a recommendation.
Insider Decl.
22
Thresholds
n/a
Buy Volume
€14M
19 ops. · all time
Sell Volume
€450,487
1 ops. · all time
Who traded when
BuySaleStefan Jernberg1 buy
Last declaration on 5 December 2024
Declarations22 total
ShareXOSLOSLO:633867
2,600 shares@ NOK 20.10100.0% of flowShareXOSLOSLO:632975
Canonical exit: 20 Feb 2025 (T+90)
10,000 shares@ NOK 20.20100.0% of flowShareXOSLOSLO:630563
Canonical exit: 26 Jan 2025 (T+90)
40,000 shares@ NOK 10.4014.9% of flowShareXOSLOSLO:611828
Canonical exit: 26 May 2024 (T+90)
135,000 shares@ NOK 10.1887.9% of flowShareXOSLOSLO:611721
Canonical exit: 23 May 2024 (T+90)
9,345 shares@ NOK 10.70100.0% of flowShareXOSLOSLO:611022
Canonical exit: 15 May 2024 (T+90)
2,552,417 shares@ NOK 10.78100.0% of flowShareXOSLOSLO:609413
Canonical exit: 29 Apr 2024 (T+90)
15,000 shares@ NOK 10.975.7% of flowShareXOSLOSLO:604469
Canonical exit: 18 Feb 2024 (T+90)
8,000 shares@ NOK 13.85100.0% of flowShareXOSLOSLO:603507
Canonical exit: 7 Feb 2024 (T+90)
7,394 shares@ NOK 13.006.1% of flowShareXOSLOSLO:598858
Canonical exit: 5 Dec 2023 (T+90)
23,003 shares@ NOK 15.17100.0% of flowShareXOSLOSLO:598037
Canonical exit: 23 Nov 2023 (T+90)
6,500 shares@ NOK 14.866.1% of flowShareXOSLOSLO:597386
Canonical exit: 19 Nov 2023 (T+90)
6,000 shares@ NOK 14.3944.7% of flowShareXOSLOSLO:590950
Canonical exit: 14 Aug 2023 (T+90)
350,000 shares@ NOK 15.0097.7% of flowShareXOSLOSLO:590524
150,000 shares@ NOK 13.7673.7% of flowShareXOSLOSLO:585617
Canonical exit: 17 Jun 2023 (T+90)
6,000 shares@ NOK 16.7955.3% of flowShareXOSLOSLO:583008
Canonical exit: 21 May 2023 (T+90)
8,500 shares@ NOK 17.015.8% of flowShareXOSLOSLO:574191
Canonical exit: 26 Jan 2023 (T+90)
12,264 shares@ NOK 18.12100.0% of flowShareXOSLOSLO:573754
Canonical exit: 22 Jan 2023 (T+90)
125,628 shares@ NOK 39.80100.0% of flowOptionXOSLOSLO:545517
4,100,000 shares@ NOK 29.00100.0% of flowShareXOSLOSLO:526568
Canonical exit: 31 May 2021 (T+90)
3,000 shares@ NOK 36.602.3% of flowShareXOSLOSLO:525622
Canonical exit: 20 May 2021 (T+90)
22 of 22 declarations
About Carasent ASA
Carasent ASA is a Norwegian company operating in the healthcare and pharmaceutical sector. It is listed on the Oslo Stock Exchange under the symbol XOSL.
